Brief: Rosetta affirms 2015 pro forma full-year revenue guidance of $10 mln to $12 mln
08/07/2015 22:38
July 8 (Reuters) - Rosetta Genomics Ltd ROSG.O : * Files pro forma financials in connection with personalizedx acquisition * Says affirms 2015 pro forma full-year revenue guidance of $10 million to $12 million * FY 2015 revenue view $10.1 million -- Thomson Reuters I/B/E/S * Source text for Eikon ID:nBwwkzsZa * Further company coverage ROSG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics